XML 49 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)
€ in Thousands, $ in Thousands
1 Months Ended 5 Months Ended 12 Months Ended
Dec. 14, 2015
USD ($)
Apr. 17, 2016
USD ($)
Oct. 31, 2014
USD ($)
Dec. 31, 2017
USD ($)
item
shares
Dec. 31, 2016
USD ($)
item
shares
Dec. 31, 2015
USD ($)
item
shares
Dec. 31, 2017
EUR (€)
Dec. 31, 2014
USD ($)
Dec. 31, 2014
EUR (€)
Average interest rate, short-term bank deposits in U.S. dollars       1.46% 1.35%        
Marketable securities impairment losses            
Deferred revenues                
Number of licensed programs to achieve substantive milestones revenues | item         1 1      
Revenue recognition under milestone method $ 7,800 $ 400 $ 7,200   $ 400 $ 7,800      
Severance expenses       365 486 484      
Net gain on derivative transactions       422 75 202      
Net gain on derivative classified to operating expenses as effective portion       422 75 177      
Net gain on derivative recorded as financial and other income, net for the ineffective portion           25      
Unrealized gain (loss) arising from derivative contracts       17 7 (19)      
Fair value of outstanding forward contracts       $ 17 $ 7        
Number of investments in affiliates | item       2          
Derivative, contract period       12 days 12 months        
Derivative, maturity date       Jan. 12, 2018 Dec. 31, 2017        
Derivative, notional amount       $ 177 $ 6,548        
Cumulative effect adjustment from adoption of ASU 2016-09 adoption                
Restricted cash       1,050 $ 993 $ 1,077      
Additional paid-in capital [Member]                  
Cumulative effect adjustment from adoption of ASU 2016-09 adoption       $ 211          
Neviah [Member]                  
Ownership percentage       25.12%     25.12%    
Keddem [Member]                  
Ownership percentage       29.41%     29.41%    
Investment amount               $ 155  
Merck Holdings [Member] | Neviah [Member] | Convertible Bridge Loan Agreement [Member]                  
Face amount | €             € 500   € 500
Loan grant date       Dec. 17, 2014          
Maturity term       18 months          
Interest rate (as a percent)       2.00%     2.00% 2.00% 2.00%
Options [Member]                  
Weighted average number of shares related to outstanding options excluded from the calculations of diluted net loss per share | shares       8,774,219 7,943,914 7,228,011